Market Trends UNITY Biotechnology tanks after failing to meet goal in eye disorder treatment trialBy admin8996erT0allMarch 24, 2025 FG Trade/E+ via Getty ImagesUNITY Biotechnology (NASDAQ:UBX) stock fell 30% after the company’s mid-stage trial for its diabetic macular edema…
Market Trends Harmony Biosciences’s sleep disorder treatment gets FDA Refuse to File letterBy admin8996erT0allFebruary 19, 2025 da-kuk/E+ via Getty ImagesHarmony Biosciences’ (NASDAQ:HRMY) stock fell about 7.3% after U.S. FDA notified the company that it will not…
